Saw Palmetto 1000 mg by Bronson — Ingredients, Evidence & Safety

Product Label

📄 Open Full PDF View on NIH DSLD →

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

2 Capsule(s) Serving Size

125 Servings

Botanical Product Type

100% Evidence Coverage

Supplement Facts — Evidence Check

Saw Palmetto powder

1000 mg

📊 Market median: 320.0mg (426 products) 📚 24 studies (Tier A: 0, B: 5)

This product: 1000mg

Other Ingredients

Microcrystalline Cellulose Modified Cellulose Magnesium Stearate Silicon Dioxide

Label Claims — Verification

❓ All Other

❓ Structure/Function

All Other (98% of products) Structure/Function (83% of products) Nutrient (17% of products)

Target Groups

Adult (18 - 50 Years) Women (not pregnant or lactating) Gluten Free

Product Information

📋 Directions for Use

Directions: As a dietary supplement for adults, take 2 capsules daily, preferably with a meal or as directed by a healthcare professional.

⚠️ Warnings & Precautions

Warning: Do not take this product if you are pregnant or nursing. Consult a healthcare professional before taking this product if you are taking medication or have a health condition.

Do not use if seal under cap is broken or missing.

Keep out of reach of children.

🧪 Formulation Notes

Extra strength Saw Palmetto 1000 mg per serving

Supports healthy prostate function Urinary health support

Non-GMO Gluten-free Soy-free

Made from high quality ingredients

Additional Information

Store at room temperature.

365 days 100% money back guaranteed

Lab tested GMP good manufacturing practice

Nutrition questions or comments? Call 1-800-235-3200 Mon. - Fri. 7 AM - 6 PM MST Sat. 8 AM - 4:30 PM MST

NEW

Product Details

UPC / SKU X002YUY9J3

DSLD Entry Date 2023-11-22

Product Type Botanical

Form Capsule

Brand Bronson

DSLD ID 298907

Data Updated 2026-04-11

Research Evidence

35 Research Sources

52 Avg Quality Score

15 Meta Analysis

11 Systematic Review

7 Rct

1 Narrative Review

1 Openfda Safety

B Serenoa repens for benign prostatic hyperplasia

Meta Analysis The Cochrane database of systematic reviews 2009

PubMed DOI

B Serenoa repens for benign prostatic hyperplasia

Meta Analysis The Cochrane database of systematic reviews 2012

PubMed DOI

B Serenoa repens for the treatment of lower urinary tract symptoms due to benign prostatic enlargement: A systematic review and meta-analysis

Meta Analysis Investigative and clinical urology 2021

PubMed DOI

B Clinical Efficacy of Serenoa repens Versus Placebo Versus Alpha-blockers for the Treatment of Lower Urinary Tract Symptoms/Benign Prostatic Enlargement: A Systematic Review and Network Meta-analysis of Randomized Placebo-controlled Clinical Trials

Systematic Review European urology focus 2021

PubMed DOI

B Non-hormonal treatment for male infertility: the potential role of Serenoa repens, selenium and lycopene

Systematic Review European review for medical and pharmacological sciences 2019

PubMed DOI

B Comparison of Serenoa repens With Tamsulosin in the Treatment of Benign Prostatic Hyperplasia: A Systematic Review and Meta-Analysis

Meta Analysis American journal of men's health 2020

PubMed DOI

B Serenoa repens monotherapy for benign prostatic hyperplasia (BPH): an updated Cochrane systematic review

Systematic Review BJU international 2012

PubMed DOI

B Effects of dietary supplements on androgenetic alopecia: a systematic review and network meta-analysis